Carfilzomib (PR-171) (UBPBio Product Code: F1301)
Usage: hover your mouse-pointer anywhere on the image above to see an enlarged portion of the image. You can also just click the image to see the original-sized version.
| Description: | Carfilzomib is a derivative of the microbially-derived natural product epoxomycin. It irreversibly inhibits the chymotrypsin-like activity of the 20S proteasome with high potency and selectivity at several orders of magnitude over epoxomycin. In 2012, Carfilzomib was approved by the FDA for use in patients with relapsed and refractory multiple myeloma. It is in clinical trials for other cancers as well |
| Order #: | UBP-F1301-25 |
| Unit Size: | 25 mg |
| Supplier: | UBPBio |
| Restrictions: | Only available in selected countries. |
| Shipping: | Ambient temp. |
| Storage: | -20 °C |
| Subcategory: | Proteasome / Deubiquitinase Inhibitors |
| More information: | Go to webpage |
Add to request list
- Phone: +49 (0)89 3799666-6
- E-mail: info@biozol.de
MoBiTec is now part of BIOZOL
All orders and requests placed via the online shop on www.mobitec.com are processed by BIOZOL Diagnostica Vertrieb GmbH.
You will receive an order confirmation by fax or e-mail. More information regarding the ordering process can be found here.
Technical Service - Product Information
Viewed